Market Overview

Benzinga's Top Pre-Market Gainers

Related SCMP
Benzinga's Top Initiations
Roth Capital Initiates Sucampo Pharmaceuticals At Buy
Related BGMD
Earnings Scheduled For August 14, 2014
Healthways, Genesis Physicians Group Unite to Enhance Healthcare - Analyst Blog

BG Medicine (NASDAQ: BGMD) soared 11.54% to $3.77 in the pre-market trading. BG Medicine obtained a CE Mark enabling the commercial sale of the CardioSCORE(TM) test in the EU.

Sucampo Pharmaceuticals (NASDAQ: SCMP) moved up 10.66% to $5.50 in the pre-market session. Sucampo Pharma received approval of an sNDA for RESCULA (unoprostone isopropyl ophthalmic solution) from the FDA.

Clearwire (NASDAQ: CLWR) added 5.60% to $2.83 in the pre-market session. Sprint Nextel (NYSE: S) is in talks to buy the 49% of Clearwire, according to people familiar with the matter.

Oncothyreon (NASDAQ: ONTY) surged 4.58% to $4.80 in the pre-market session. Oncothyreon's trailing-twelve-month ROE is -33.87%.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (CLWR + BGMD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters